Evidence supporting the use of: Phaeophyceae (unspecified)
For the health condition: Rheumatoid Arthritis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Phaeophyceae, or brown algae (such as Ascophyllum nodosum, Laminaria, and Fucus species), have been investigated for their potential anti-inflammatory properties, which are relevant to conditions like Rheumatoid Arthritis (RA). The primary bioactive components of Phaeophyceae include fucoidans (sulfated polysaccharides), phlorotannins, and alginates, all of which have shown anti-inflammatory effects in preclinical models. A number of in vitro and animal studies indicate that extracts from brown algae can suppress pro-inflammatory cytokines, reduce oxidative stress, and modulate immune responses. For example, fucoidan has demonstrated the ability to inhibit NF-κB signaling and downregulate inflammatory mediators in cell and animal models of arthritis.

Despite these promising findings, robust clinical evidence in humans with RA is lacking. Only limited pilot or observational studies exist, and they often suffer from small sample sizes or methodological weaknesses. There is no established tradition of using Phaeophyceae specifically for RA in historical medical systems, though seaweeds have been consumed for general health in coastal cultures. Therefore, while there is scientific rationale and preclinical evidence supporting anti-inflammatory effects, there is insufficient high-quality clinical research to confirm the benefit of Phaeophyceae for RA in humans. On a scale of 0-5, the evidence rates a 2, reflecting preclinical but not clinical support.

More about Phaeophyceae (unspecified)
More about Rheumatoid Arthritis

Products containing Phaeophyceae (unspecified)

We currently have no products on Vitabase that contain this ingredient.